Skip to main content

Table 2 Clinical presentation of the six cystic fibrosis patients who yielded Mycobacterium lentiflavum isolates

From: Prevalence of Mycobacterium lentiflavum in cystic fibrosis patients, France

  Mean Standard deviation Limits
Age, y 22.2 +/−11.4 [14.6 - 44.1]
Pedatric/Adults 3/3   
Male, % 100   
FEV, % predicted 67 % +/−19 % [46 – 93 %]
BMI, kg/m2 20 +/−1.9 [17.2 – 22.4]
Infected (met ATS criteria)a 2/6   
Diabetes 3/6   
Exocrine pancreatic disease 6/6   
Pseudomonas aeruginosa 5/6   
Stenotrophomonas maltophilia 4/6   
Previous NTM isolationb 2/6   
MS Staphylococcus aureus 6/6   
Aspergillus sp. 5/6   
Other co-infectionc 4/6   
Azithromycin prophylaxisd 6/6   
Lung transplanted after isolation 1/6   
  1. FEV forced expiratory volume, ATS American Thoracic Society, BMI body mass index, NTM nontuberculous mycobacteria, MS methicillin susceptible
  2. aPatients who fulfilled the American Thoracic Society’s microbiological and clinical criteria for NTM pulmonary disease [12]
  3. bMycobacterium avium complex
  4. cNocardia sp., Penicillium sp., Serratia sp., Achromobacter sp., Scedosporium sp
  5. d250mg per os three times a week